Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.41%0700.HK-6.14%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.20%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.38%0857.HK-1.46%UNH-10.21%1288.HK-1.42%PM-0.85%0005.HK-1.94%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.72%AUDUSD-1.57%EURAUD+1.07%AUDCHF-1.04%AUDCAD-1.04%GBPAUD+0.99%AUDNZD-0.97%NZDJPY-0.77%GBPJPY-0.74%CADJPY-0.69%EURJPY-0.69%AUDSGD-0.68%CHFJPY-0.68%AUDDKK-0.62%NZDUSD-0.60%GBPUSD-0.57%USDCHF+0.56%USDCAD+0.54%AUDNOK-0.52%EURUSD-0.51%GBPTRY+0.41%GBPHKD+0.32%USDMXN+0.29%GBPMXN-0.28%NZDMXN+0.28%USDZAR+0.25%USDTHB+0.24%USDTRY+0.21%EURZAR+0.18%USDJPY-0.18%USDNOK+0.17%CHFNOK+0.16%USDILS+0.16%GBPZAR+0.14%NOKJPY-0.12%USDCNH-0.12%USDSEK+0.12%USDPLN+0.11%EURCNH-0.11%EURNOK+0.10%CHFSEK+0.10%GBPSGD-0.10%EURNZD+0.09%NZDCAD-0.08%NZDCHF-0.08%EURHKD-0.08%USDDKK+0.07%EURGBP+0.06%EURSGD-0.06%PLNJPY-0.06%GBPCAD-0.05%EURCZK+0.05%SGDJPY+0.05%EURSEK+0.05%EURCHF+0.04%EURPLN+0.04%USDCOP-0.04%GBPNZD+0.04%EURCAD+0.02%NZDSGD+0.02%GBPCHF-0.02%CADCHF+0.01%USDSGD+0.01%USDHKD-0.01%CHFSGD0.00%EURDKK0.00%XAGUSD+0.80%GAGUSD+0.80%XNGUSD-0.74%UKOIL+0.68%XAUUSD+0.57%GAUUSD+0.57%USOIL+0.48%W1-0.43%HG1+0.36%XPTUSD+0.25%C1-0.23%S1-0.15%BTCUSD-3.20%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.87%ZECUSDT-6.08%XMRUSDT-1.33%DOGEUSD+55.95%LINKUSD-2.91%XLMUSD-3.40%BCHUSDT-3.08%LTCUSD+47.50%UNIUSD-2.28%SUIUSD-2.64%TONUSD+59.18%HBARUSDT-4.52%TAOUSDT-2.65%AAVEUSD-3.01%ONDOUSDT-4.94%ICPUSDT-1.61%DOTUSDT-3.50%WLDUSDT-2.82%ARBUSDT-4.74%ATOMUSDT-2.31%INJUSDT-6.56%STXUSDT-2.39%PYTHUSDT-0.42%TIAUSDT-3.10%FETUSDT-3.86%JUPUSDT+1.01%SEIUSDT-2.00%GRTUSDT-2.80%OPUSDT-2.63%IOTAUSDT-2.25%POLUSDT-1.64%WIFUSDT-2.25%AXSUSDT-2.33%EOSUSDT-3.95%IMXUSDT-2.35%FARTCOINUSDT-5.71%GALAUSDT-1.65%DYDXUSDT-2.06%ORDIUSDT-2.36%NOTUSDT+0.86%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.41%0700.HK-6.14%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.20%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.38%0857.HK-1.46%UNH-10.21%1288.HK-1.42%PM-0.85%0005.HK-1.94%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.72%AUDUSD-1.57%EURAUD+1.07%AUDCHF-1.04%AUDCAD-1.04%GBPAUD+0.99%AUDNZD-0.97%NZDJPY-0.77%GBPJPY-0.74%CADJPY-0.69%EURJPY-0.69%AUDSGD-0.68%CHFJPY-0.68%AUDDKK-0.62%NZDUSD-0.60%GBPUSD-0.57%USDCHF+0.56%USDCAD+0.54%AUDNOK-0.52%EURUSD-0.51%GBPTRY+0.41%GBPHKD+0.32%USDMXN+0.29%GBPMXN-0.28%NZDMXN+0.28%USDZAR+0.25%USDTHB+0.24%USDTRY+0.21%EURZAR+0.18%USDJPY-0.18%USDNOK+0.17%CHFNOK+0.16%USDILS+0.16%GBPZAR+0.14%NOKJPY-0.12%USDCNH-0.12%USDSEK+0.12%USDPLN+0.11%EURCNH-0.11%EURNOK+0.10%CHFSEK+0.10%GBPSGD-0.10%EURNZD+0.09%NZDCAD-0.08%NZDCHF-0.08%EURHKD-0.08%USDDKK+0.07%EURGBP+0.06%EURSGD-0.06%PLNJPY-0.06%GBPCAD-0.05%EURCZK+0.05%SGDJPY+0.05%EURSEK+0.05%EURCHF+0.04%EURPLN+0.04%USDCOP-0.04%GBPNZD+0.04%EURCAD+0.02%NZDSGD+0.02%GBPCHF-0.02%CADCHF+0.01%USDSGD+0.01%USDHKD-0.01%CHFSGD0.00%EURDKK0.00%XAGUSD+0.80%GAGUSD+0.80%XNGUSD-0.74%UKOIL+0.68%XAUUSD+0.57%GAUUSD+0.57%USOIL+0.48%W1-0.43%HG1+0.36%XPTUSD+0.25%C1-0.23%S1-0.15%BTCUSD-3.20%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.87%ZECUSDT-6.08%XMRUSDT-1.33%DOGEUSD+55.95%LINKUSD-2.91%XLMUSD-3.40%BCHUSDT-3.08%LTCUSD+47.50%UNIUSD-2.28%SUIUSD-2.64%TONUSD+59.18%HBARUSDT-4.52%TAOUSDT-2.65%AAVEUSD-3.01%ONDOUSDT-4.94%ICPUSDT-1.61%DOTUSDT-3.50%WLDUSDT-2.82%ARBUSDT-4.74%ATOMUSDT-2.31%INJUSDT-6.56%STXUSDT-2.39%PYTHUSDT-0.42%TIAUSDT-3.10%FETUSDT-3.86%JUPUSDT+1.01%SEIUSDT-2.00%GRTUSDT-2.80%OPUSDT-2.63%IOTAUSDT-2.25%POLUSDT-1.64%WIFUSDT-2.25%AXSUSDT-2.33%EOSUSDT-3.95%IMXUSDT-2.35%FARTCOINUSDT-5.71%GALAUSDT-1.65%DYDXUSDT-2.06%ORDIUSDT-2.36%NOTUSDT+0.86%RONINUSDT-2.92%
PF

Pfizer Inc. (PFE)

NYSE • Healthcare

$28.06
-$0.41 (-1.4%)
Market closed

November 18, 2026 at 21:00 UTC

Open$28.06
Day Range$28 - $28.54
Avg. Volume (3M)36.2M
Market Cap$159.9B
P/E Ratio39.5
52 Week Range
$23.62$31.44
Next EarningsIn 75 daysFeb 2, 2027

Interactive Chart

02:28:53 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$16.5B100%
Gross Profitminus cost of goods$12.5B76%
Operating Incomeminus R&D and overhead$3.6B22%
Net Incomeminus taxes and the rest$3.2B20%

In plain terms: out of every $100 in revenue, Pfizer Inc. keeps $20 as net profit.

Fundamentals & Financials

Revenue (TTM)
$63.6B
Net Income (TTM)
$4B
EPS (TTM)
$0.71
ROA (TTM)
1.97%
Current Ratio
1.42
Dividend Yield
1.5%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+3.9%Q2 2026$0.75
+12.9%Q3 2026$0.77
+18.4%Q4 2026$0.87
Next

Feb 2

in 75 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +18.4%

Pfizer beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported November 3, 2026, as revenue of $16.583 billion topped the $15.852 billion estimate, +4.6%, even as revenue slipped 0.4% year over year from $16.654 billion. Adjusted EPS of $0.87 topped the $0.73 estimate, +18%, and was essentially flat versus $0.87 a year ago, while net income fell 8.4% year over year to roughly $3.2 billion from $3.541 billion. Profitability held with a gross margin of about 76% and operating margin near 22%, translating into operating income of roughly $3.7 billion alongside gross profit of about $12.6 billion. The quarter generated operating cash flow of about $5.4 billion, and Pfizer paid roughly $2.5 billion in dividends. For the next period, consensus calls for EPS of $0.72 on revenue of $17.064 billion.

View full earnings history

About Pfizer Inc.

Pfizer Inc. develops, makes, and sells prescription medicines and vaccines worldwide. Listed on the NYSE as PFE, the company operates in the pharmaceutical business and generated $62.6 billion of revenue in FY2025. Its portfolio spans branded therapies, biosimilars, hospital injectables, and vaccines used across a wide range of treatment and prevention settings.

Name
Pfizer Inc.
CEO
Albert Bourla
Industry
Healthcare
Year Founded
1849
Employees
75,000

Today's Snapshot

AI-generated

PFE closed 1.4% lower at 28.06, in line with a weaker sector. Pfizer struck a deal with Starna, a cell-therapy company, to develop treatments given inside the body.

Trading Volume

Above 10d avg 35.9M

37.2M

vs S&P 500 Today

Underperforming Market

-1.18%

Updated: November 18, 2026 at 21:17 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
Pfizer’s technical picture leans negative on momentum and price structure despite mixed longer-term moving averages. Momentum and CCI readings are weak and RSI is below neutral, while the MACD is slightly negative, collectively pointing to downside pressure. Short- and medium-term moving averages sit above the market, confirming recent weakness, and on-balance volume favors sellers; volatility is moderate by ATR. The classic pivot is above the current price and aligns with resistive bias. Technical takeaway: sell bias persists as momentum, moving averages and volume favor the downside.
All signals
  • EMA (5 indicators)$27.27 - $29.19
    Sell
  • RSI (14)37.40
    Neutral
  • Stochastic %K (14, 3, 3)5.55
    Buy
  • MACD Level (12, 26)-0.13
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.